Page 91 - 79_02
P. 91

Long-­-life	
  supplementation	
  with	
  atenolol…	
  	
  

	
  

                                                                                                                                   	
  
Figure	
   3.-­-	
   Double	
   bond	
   index	
   (DBI)	
   and	
   peroxidizability	
   index	
   (PI)	
   in	
   heart	
   (A)	
   and	
   SKM	
   (B)	
  
mitochondrial	
   fatty	
   acids	
   from	
   control	
   and	
   atenolol	
   treated	
   mice.	
   Values	
   are	
   means	
   ±	
   SEM	
   from	
   6	
  
(heart)	
  or	
  5-­-6	
  (SKM)	
  different	
  animals	
  and	
  are	
  expressed	
  as	
  percentage	
  of	
  those	
  in	
  the	
  controls	
  for	
  
each	
   parameter.	
   Control	
   values:	
   232.60±5.90	
   (DBI,	
   heart);	
   268.39±8.02	
   (PI,	
   heart);	
   203.91±3.38	
  
(DBI,	
   SKM);	
   217.36±4.52	
   (PI,	
   SKM).	
   For	
   calculation	
   of	
   DBI	
   and	
   PI	
   values	
   see	
   the	
   Materials	
   and	
  
Methods	
   section.	
   Asterisks	
   represent	
   significant	
   differences	
   between	
   the	
   control	
   and	
   the	
   atenolol	
  
group.	
  *	
  P<0.05;	
  **	
  P<0.01;	
  ***	
  P<0.001.	
  
	
  

        Oxidative	
  damage	
  in	
  heart	
  mtDNA	
  significantly	
  decreased	
  from	
  20.65±3.81	
  8-­-
oxodG/105dG	
  in	
  Old	
  Controls	
  to	
  10.07±1.37	
  in	
  Old	
  AT	
  (P<0.05),	
  whereas	
  in	
  the	
  case	
  
of	
   SKM	
   the	
   trend	
   to	
   decrease	
   in	
   the	
   AT	
   group	
   did	
   not	
   reach	
   statistical	
   significance	
  
(results	
  not	
  shown).	
  

        Protein	
   oxidation,	
   glycoxidation	
   and	
   lipoxidation	
   markers	
   are	
   shown	
   in	
  
Figures	
   4	
   and	
   5.	
   In	
   heart	
   mitochondria	
   all	
   the	
   five	
   markers	
   measured,	
   GSA,	
   AASA,	
  
CEL,	
  CML	
  and	
  MDAL,	
  were	
  significantly	
  lower	
  in	
  Old	
  AT-­-animals	
  than	
  in	
  Old	
  controls	
  
(Figure	
   4).	
   In	
   SKM	
   mitochondria	
   the	
   values	
   of	
   GSA,	
   AASA,	
   CML	
   and	
   MDAL	
   were	
  
significantly	
   lower	
   in	
   the	
   atenolol	
   treated	
   animals.	
   These	
   decreases	
   were	
   rather	
  
strong	
  and	
  ranged	
  from	
  31%	
  to	
  51%	
  depending	
  on	
  the	
  parameter	
  measured	
  and	
  the	
  
tissue	
   considered.	
   Only	
   in	
   the	
   case	
   of	
   CEL	
   the	
   decrease	
   shown	
   by	
   AT	
   compared	
   to	
  
controls	
   did	
   not	
   reach	
   statistical	
   significance	
   (Figure	
   5).	
   Concerning	
   mitochondrial	
  
biogenesis,	
   antioxidant	
   factors	
   and	
   signaling	
   proteins,	
   SIRT1	
   increased	
   and	
   Nrf2	
  
decreased	
  in	
  Old	
  AT	
  in	
  heart	
  (P<0.05)	
  but	
  not	
  in	
  SKM	
  mitochondria.	
  TFAM	
  decreased	
  
in	
   Old	
   AT	
   in	
   SKM	
   (P<0.05)	
   but	
   not	
   in	
   heart	
   mitochondria,	
   while	
   PGC1	
   did	
   not	
   show	
  
significant	
  changes	
  in	
  any	
  organ	
  (results	
  not	
  shown).	
  The	
  ratio	
  of	
  the	
  phosphorylated	
  

                                                                                                                            	
   261	
  

	
  
   86   87   88   89   90   91   92   93   94   95   96